211
Participants
Start Date
July 15, 2021
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Speech-Language Teletherapy
Access to speech-language teletherapy will be provided as a supplement to Usual Care for subjects randomized to this group. Access is provided by way of 1) direct referral by the clinical team to a teletherapist; 2) availability of a teletherapy slot. All teletherapy providers will be licensed speech-language pathologists (SLPs) and/or credentialed teachers of the deaf (TODs) with specialized training to work with children who are D/HH using an LSL approach. Fluent English and Spanish speaking providers will be matched to the child's home, native language. Teletherapy itself is within routine clinical care and is not considered a research activity. Children who randomize to the Low TT study arm will receive access to an 18-month course of weekly teletherapy, in accordance with the centers' standard of care. The exact details of the therapy course and frequency will be determined based on individual family needs.
Rady Children's Hospital - San Diego, San Diego
The University of California - San Francisco, San Francisco
Lucile Packard Children's Hospital Stanford, Palo Alto
UCSF Benioff Children's Hospital - Oakland, Oakland
Seattle Children's Hospital, Seattle
Patient-Centered Outcomes Research Institute
OTHER
University of California, San Francisco
OTHER